Literature DB >> 8882338

In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus.

A Sabile1, A Rhodes-Feuillette, F Z Jaoui, J Tobaly-Tapiero, M L Giron, J Lasneret, J Périès, M Canivet.   

Abstract

We demonstrate in this article that human foamy virus (HFV) fails to induce interferon (IFN) production in two different human tissue culture cell lines: U373-MG and AV3. We also show the effect of human alpha-, beta- and gamma IFN on the multiplication cycle of HFV. Treatment of cells with 100 IU/ml of any IFN led to strong inhibition of an HFV-induced cytopathic effect. This effect was associated with a significant diminution of reverse transcriptase activity in supernatant fluids of IFN-treated infected cultures, and a substantial decrease in viral particle production, as detected by electron microscopy. All these effects were accompanied by strong inhibition of both viral proteins and RNA synthesis, as well as almost total disappearance of free and integrated proviral DNA. In light of our data, human IFN action on HFV seems to be mediated by a mechanism which differs from that observed in the case of other retroviruses (type C and D for instance); however, it evokes that described for HIV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882338     DOI: 10.1016/0923-2516(96)80237-8

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  16 in total

1.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene.

Authors:  H Schmeisser; J Mejido; C A Balinsky; A N Morrow; C R Clark; T Zhao; K C Zoon
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm.

Authors:  Xiaomei Hu; Wei Yang; Ruikang Liu; Yunqi Geng; Wentao Qiao; Juan Tan
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

5.  Innate sensing of foamy viruses by human hematopoietic cells.

Authors:  Réjane Rua; Alice Lepelley; Antoine Gessain; Olivier Schwartz
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

6.  Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects.

Authors:  V Falcone; M Schweizer; A Toniolo; D Neumann-Haefelin; A Meyerhans
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus.

Authors:  Juan Tan; Wentao Qiao; Jian Wang; Fengwen Xu; Yue Li; Jun Zhou; Qimin Chen; Yunqi Geng
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

Review 8.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

9.  The promyelocytic leukemia protein does not mediate foamy virus latency in vitro.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication.

Authors:  Anshuman Das; Phat X Dinh; Debasis Panda; Asit K Pattnaik
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.